Company · AMGN
Amgen Inc.
Name as listed on its exchange; filed with the SEC as AMGEN INC.
Nasdaq's symbol directory lists AMGN on Nasdaq as “Amgen Inc. - Common Stock”.
In the 12 months to Nov 19, 2026: insiders sold on 4 occasions ($4.1M); 4 planned-sale notices; 26 congressional trade disclosures; 4 company reports (Form 8-K, since May 26, 2026).
Insider trades · SEC Form 4
Those inside the hall
Open-market purchases and sales only. Legs one person filed for one day are combined.
Who traded
- Derek Miller, SVP, Human Resources sold $1.6M
- Rachna Khosla, SVP, Business Development sold $1.3M
- Nancy A. Grygiel, SVP & CCO sold $1.2M
Every trade (4)
- SELLRachna Khosla, SVP, Business Development sold $521K
- SELLRachna Khosla, SVP, Business Development sold $825K
- SELLDerek Miller, SVP, Human Resources sold $1.6M
- SELLNancy A. Grygiel, SVP & CCO sold $1.2M
Planned sales · SEC Form 144
Notice given
A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice
- Khosla Rachna $517K
- Khosla Rachna $828K
- Derek Miller $1.6M
- Grygiel Nancy A. $1.2M
Congress · STOCK Act
The Althing
Periodic transaction reports. Amounts are the ranges members report; the trade date is when it happened, the report can come up to 45 days later.
- David J. Taylor (R-OH02): Sale $1,001 - $15,000
- David J. Taylor (R-OH02): Sale $1,001 - $15,000
- Sheldon Whitehouse (D-RI): Sale (Full) $15,001 - $50,000
- David J. Taylor (R-OH02): Purchase $1,001 - $15,000
- Rohit Khanna (D-CA17): Purchase $1,001 - $15,000
- David J. Taylor (R-OH02): Sale $1,001 - $15,000
- David J. Taylor (R-OH02): Sale $1,001 - $15,000
- Sheldon Whitehouse (D-RI): Sale (Partial) $1,001 - $15,000
- Rohit Khanna (D-CA17): Sale $1,001 - $15,000
- Rohit Khanna (D-CA17): Purchase $1,001 - $15,000
- Rohit Khanna (D-CA17): Purchase $1,001 - $15,000
- Rohit Khanna (D-CA17): Purchase $1,001 - $15,000
- David J. Taylor (R-OH02): Purchase $1,001 - $15,000
- Rohit Khanna (D-CA17): Purchase $1,001 - $15,000
- Rohit Khanna (D-CA17): Purchase $15,001 - $50,000
- Rohit Khanna (D-CA17): Sale $15,001 - $50,000
- Rohit Khanna (D-CA17): Purchase $15,001 - $50,000
- Maria Elvira Salazar (R-FL27): Sale $15,001 - $50,000
- Rohit Khanna (D-CA17): Sale $15,001 - $50,000
- Alan Armstrong (R-OK): Sale (Full) $15,001 - $50,000
- Maria Elvira Salazar (R-FL27): Purchase $15,001 - $50,000
- David J. Taylor (R-OH02): Sale $1,001 - $15,000
- Rohit Khanna (D-CA17): Purchase $15,001 - $50,000
- David J. Taylor (R-OH02): Sale $1,001 - $15,000
- Rohit Khanna (D-CA17): Sale $15,001 - $50,000
- David J. Taylor (R-OH02): Purchase $1,001 - $15,000
Executive branch · OGE Form 278-T
Reported by the President
13 confirmed trades on scanned reports whose security name matches this company's own filed name exactly (letter case, punctuation and Inc/Corp-style endings aside). All of Donald J. Trump's reports
- Purchase: AMGEN INC $1,001 – $15,000
- Purchase: AMGEN INC $15,001 – $50,000
- Sale: AMGEN INC $1,001 – $15,000
- Purchase: AMGEN INC $100,001 – $250,000
- Purchase: AMGEN INC $15,001 – $50,000
- Sale: AMGEN INC $1,001 – $15,000
- Sale: AMGEN INC $15,001 – $50,000
- Purchase: AMGEN INC $50,001 – $100,000
- Purchase: AMGEN INC $1,001 – $15,000
- Purchase: AMGEN INC $1,001 – $15,000
Showing the latest 10 of 13.
Company reports · SEC Form 8-K
In its own words
Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.
- Results of operations and financial condition Nov 3, 2026
- Departure or appointment of directors or officers Oct 27, 2026
- Results of operations and financial condition Aug 4, 2026
- Material cybersecurity incident Jul 31, 2026
Lobbying · Senate LDA reports
Lobbying filed
63 quarterly lobbying reports for 2026 naming Amgen Inc. as the client: 3 filed by the company itself, 60 by outside firms it hired. Each line is one report as filed; an amended report is a line of its own. An outside firm states what the company paid it; the company's own report states its whole lobbying spend, which can include those fees, so the lines are not added up. Reports are collected in batches and a quarter can be missing here; the full record is at lda.gov.
- The company itself $3.1M
- TODD STRATEGY GROUP $80K
- TARPLIN, DOWNS & YOUNG, LLC $60K
- S-3 GROUP $60K
- MARSHALL & POPP, LLC $60K
- WILLIAMS AND JENSEN, PLLC $60K
- MILLER STRATEGIES, LLC $60K
- TIBER CREEK GROUP $60K
- ACG ADVOCACY $50K
- AVENUE SOLUTIONS $50K
- BGR GOVERNMENT AFFAIRS $50K
- FORBES-TATE $50K
- OGR $50K
- AKIN GUMP STRAUSS HAUER & FELD $50K
- CAPITOL COUNSEL LLC $50K
- EMPIRE CONSULTING GROUP $50K
- HILLNORTH LLC $38K
- JEFFREY J. KIMBELL & ASSOCIATES, INC. $8K
- MICHAEL J. LAMOUREUX no amount stated
- FEDERAL HEALTH COUNSEL, LLC no amount stated
- The company itself $2.4M
- TODD STRATEGY GROUP $80K
- TIBER CREEK GROUP $60K
- S-3 GROUP $60K
- MARSHALL & POPP, LLC $60K
Showing 25 of 63.
Sources: SEC EDGAR (Forms 4, 144 and 8-K), Senate LDA lobbying reports, OGE Form 278-T reports on whitehouse.gov and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.